drugset / Trial / NCT05971654
Effect Of Azithromycin in Women at Risk of Preterm Labour
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is to evaluate the benefit of the addition of azithromycin to standard treatments to prolong pregnancy in women having intact membranes and is at risk of or in preterm labour.
Timeline
- Start
- 2023-07-30
- Primary completion
- 2023-09-30
- Completion
- 2024-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 500 mg | Oral |
Indications
No indication recorded.